ILiAD Biotechnologies is utilizing its B-Tech technology to develop next-generation vaccines to prevent infectious diseases and improve lives. Its lead candidate, BPZE1, is the most advanced next-generation vaccine for the prevention of pertussis (whooping cough), a serious disease caused by Bordetella pertussis.
Contributions
Contributors
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
